USPTO 2015–2025 USPTO PatentsView US Corporation

Cameron Health, Inc.

USPTO PatentsView assignee record - 72 granted patents across 8 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

RSS updates for this company

The verdict

According to USPTO PatentsView, Cameron ranks #4,808 of 49,997 tracked US assignees by granted-patent volume, with 72 patents across 8 technology areas.

#4,808
of 49,997 US assignees by volume
Top 49%
by Innovation Score (35.6/100)
16.3
avg claims per patent
-80%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4808 · US Corporation #4,808 · 72 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 72 grants
  • TOP-DECILE #4,808/49,997
  • PHOTO-FINISH ALI Group S R L…
  • CPC-NARROW A61N · 8 areas
  • INNOV-THIN 35.6/100
  • CLAIMS-RICH 16.3 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -80% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: ALI Group S.R.L.—CARPIGIANI (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Cameron

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Cameron's Innovation Score is 35.6/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Cameron's grants concentrate

Cameron Health, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 95.8% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2015 (17 grants) versus a trough of 1 in 2022. By volume, Cameron sits between ALI Group S.R.L.—CARPIGIANI and Daewoo Shipbuilding & Marine Engineering Co., Ltd..

Cameron's three-year grant acceleration

Cameron Health, Inc. shows 2 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Cameron's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Cameron holds 72 patents at rank #4,808, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Cameron

By rank, the assignees closest to #4,808 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Cameron's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cameron, neither rank-band nor same-CPC leaders (those blocks stay above).

Cameron's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 201520162017201820192020202120222024 1
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Cameron Health, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 17 23.6%
2016 16 22.2%
2017 13 18.1%
2018 11 15.3%
2019 3 4.2%
2020 6 8.3%
2021 4 5.6%
2022 1 1.4%
2024 1 1.4%

Where it ranks

Overall rank by patents

#4,808

of 49,997 tracked assignees

Innovation Score

35.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Cameron Health, Inc.'s patent record in context - here's where to go next.

  • Cameron Health, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 95.8% of its portfolio - see every assignee active in that class. Explore A61N
  • Ranked #4,808 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Cameron Health, Inc. against ALI Group S.R.L.—CARPIGIANI, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 35.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.